The legislation would end tax breaks on prescription drug commercials in Maryland, allowing companies that can deduct the cost of commercials for prescription drug medications as a business expense. The money would be used to reduce health care costs and stabilize Medicaid and the state's Medicaid. However, health care advocates argue that the funds would be better spent on bringing costs down. Pharmaceutical companies argue that singling out their industry is unfair and a violation of free speech. The state would allocate $5 million to the Department of Health for Medicaid operations and $5 billion to medical assistance in medical operations. The remaining funds will go towards the implementation of new federal restrictions on who qualifies for Medicaid. The bill has been supported by 73% of respondents in a new poll by Opinion Works, who believe it could help Marylanders make sure they have the health care they need. The final vote on the bill is set to go to the House of Representatives.